PATENT CLAIM ANALYSIS

Application Number: 15885464
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "468000"]

Abstract:
The invention provides compositions and methods for long term release of Gonadotropin-releasing hormone (GnRH) antagonists, and uses thereof. Specifically, the invention provides polymer compositions and methods for controlled release of GnRH antagonists.

Claim (Index 48):
A method for maintaining a therapeutic level of cetrorelix in a subject for a period ranging from about 1 month to about 6 months, the method comprising administering to said subject a composition comprising cetrorelix and a polymer, said polymer comprising or poly-lactic co-glycolic acid (PLGA) in a lactide:glycolide molar ratio between 50:50 and 100:0, wherein cetrorelix is present in an amount of 5%-90% of the mass of said implant, and said polymer is present in an amount of 10%-50% of the mass of said implant.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 86.0
- Lexical Diversity: 1.52
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13669093', '10894956', '14697220', '13318320', '14124631']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7512908618332235
- 35 USC 102 Novelty (BERT): 0.527150768335204
- Combined Prediction Score: 0.7288768524834215
- Mean Citation Score: 310.093858
- Max Citation Score: 345.06564
- Similarity Product: 219.2452250773001

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test